ResearcherIcahn School of Medicine at Mount SinaiNo recent work listed
Jian Jun Jin
Matched on ORCID iD 0000-0002-2387-3862; OpenAlex author ID A5035411478. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers
Papers 3
- Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.2c01505↗
- Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.3c01521↗
- Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism. Co-author DOI 10.1016/j.celrep.2019.09.056↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xufen Yu · 2 shared papers, 2019–2023 · strength 0.22
- Paper Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. DOI 10.1021/acs.jmedchem.3c01521↗
- Paper Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism. DOI 10.1016/j.celrep.2019.09.056↗
- Ning Sun · 1 shared paper, 2023 · strength 0.18
- Nithya Sivaram · 1 shared paper, 2019 · strength 0.07
- Claudia Tonelli · 1 shared paper, 2019 · strength 0.07
- Alex J. Bott · 1 shared paper, 2019 · strength 0.07
- Daniel J. Murphy · 1 shared paper, 2019 · strength 0.07
- Jennifer P. Morton · 1 shared paper, 2019 · strength 0.07
- Richard Z Lin · 1 shared paper, 2019 · strength 0.07
- Wei‐Xing Zong · 1 shared paper, 2019 · strength 0.07
- Nathiya Muthalagu · 1 shared paper, 2019 · strength 0.07
- David Arthur Tuveson · 1 shared paper, 2019 · strength 0.07
- Howard C. Crawford · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.